Talaris Therapeutics goes public
Boston-based Talaris Therapeutics Inc, a cell therapy company, has raised about $150 million for its IPO after pricing its over 8.8 million shares at $17 per share.
Boston-based Talaris Therapeutics Inc, a cell therapy company, has raised about $150 million for its IPO after pricing its over 8.8 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination